Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort.

Eur Urol Open Sci · 2025 · PMC11869531 · PMID 40026657

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Furthermore, a decreasing trend was observed for receipt of systemic therapy (from 59% to 51%), whereas increasing trends were observed for BSC (from 36% to 39%) and nephrectomy (from 6% to 10%), as shown in Fig. 1 and Supplementary Table 1 .

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.